A citation-based method for searching scientific literature

Koya Fukunaga, Eiji Hishinuma, Masahiro Hiratsuka, Ken Kato, Takuji Okusaka, Takeo Saito, Masashi Ikeda, Teruhiko Yoshida, Hitoshi Zembutsu, Nakao Iwata, Taisei Mushiroda. J Hum Genet 2021
Times Cited: 9







List of co-cited articles
92 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications.
Yusmiati Liau, Simran Maggo, Allison L Miller, John F Pearson, Martin A Kennedy, Simone L Cree. Pharmacogenomics 2019
24
66

Long-Read Single Molecule Real-Time Full Gene Sequencing of Cytochrome P450-2D6.
Wanqiong Qiao, Yao Yang, Robert Sebra, Geetu Mendiratta, Andrea Gaedigk, Robert J Desnick, Stuart A Scott. Hum Mutat 2016
58
66

Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.
Henk P J Buermans, Rolf H A M Vossen, Seyed Yahya Anvar, William G Allard, Henk-Jan Guchelaar, Stefan J White, Johan T den Dunnen, Jesse J Swen, Tahar van der Straaten. Hum Mutat 2017
39
66

Genetic variation in the human cytochrome P450 supergene family.
Kohei Fujikura, Magnus Ingelman-Sundberg, Volker M Lauschke. Pharmacogenet Genomics 2015
95
44

PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation.
Adam S Gordon, Robert S Fulton, Xiang Qin, Elaine R Mardis, Deborah A Nickerson, Steve Scherer. Pharmacogenet Genomics 2016
78
44

The global spectrum of protein-coding pharmacogenomic diversity.
G E B Wright, B Carleton, M R Hayden, C J D Ross. Pharmacogenomics J 2018
49
44

An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people.
Matthew R Nelson, Daniel Wegmann, Margaret G Ehm, Darren Kessner, Pamela St Jean, Claudio Verzilli, Judong Shen, Zhengzheng Tang, Silviu-Alin Bacanu, Dana Fraser,[...]. Science 2012
467
44

Integrating rare genetic variants into pharmacogenetic drug response predictions.
Magnus Ingelman-Sundberg, Souren Mkrtchian, Yitian Zhou, Volker M Lauschke. Hum Genomics 2018
103
44


An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
Yitian Zhou, Souren Mkrtchian, Masaki Kumondai, Masahiro Hiratsuka, Volker M Lauschke. Pharmacogenomics J 2019
65
44


Long read nanopore sequencing for detection of HLA and CYP2D6 variants and haplotypes.
Ron Ammar, Tara A Paton, Dax Torti, Adam Shlien, Gary D Bader. F1000Res 2015
67
44

Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data.
Maaike van der Lee, William G Allard, Rolf H A M Vossen, Renée F Baak-Pablo, Roberta Menafra, Birgit A L M Deiman, Maarten J Deenen, Patrick Neven, Inger Johansson, Stefano Gastaldello,[...]. Sci Transl Med 2021
17
44

PharmVar GeneFocus: CYP2D6.
Charity Nofziger, Amy J Turner, Katrin Sangkuhl, Michelle Whirl-Carrillo, José A G Agúndez, John L Black, Henry M Dunnenberger, Gualberto Ruano, Martin A Kennedy, Michael S Phillips,[...]. Clin Pharmacol Ther 2020
97
44


Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model.
Seung-Been Lee, Marsha M Wheeler, Karynne Patterson, Sean McGee, Rachel Dalton, Erica L Woodahl, Andrea Gaedigk, Kenneth E Thummel, Deborah A Nickerson. Genet Med 2019
49
33


Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data.
Yitian Zhou, Kohei Fujikura, Souren Mkrtchian, Volker M Lauschke. Front Pharmacol 2018
42
33

Genetic variation in human drug-related genes.
Charlotta Pauline Irmgard Schärfe, Roman Tremmel, Matthias Schwab, Oliver Kohlbacher, Debora Susan Marks. Genome Med 2017
61
33


Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
Volker M Lauschke, Lili Milani, Magnus Ingelman-Sundberg. AAPS J 2017
74
33


Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
Tõnis Tasa, Kristi Krebs, Mart Kals, Reedik Mägi, Volker M Lauschke, Toomas Haller, Tarmo Puurand, Maido Remm, Tõnu Esko, Andres Metspalu,[...]. Eur J Hum Genet 2019
19
33

Genetic associations with clozapine-induced myocarditis in patients with schizophrenia.
Paul Lacaze, Kathlyn J Ronaldson, Eunice J Zhang, Ana Alfirevic, Hardik Shah, Leah Newman, Maya Strahl, Melissa Smith, Chad Bousman, Ben Francis,[...]. Transl Psychiatry 2020
13
33

Prediction of CYP2D6 phenotype from genotype across world populations.
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Teri Klein, J Steven Leeder. Genet Med 2017
270
33



Constellation: a tool for rapid, automated phenotype assignment of a highly polymorphic pharmacogene, CYP2D6, from whole-genome sequences.
Greyson P Twist, Andrea Gaedigk, Neil A Miller, Emily G Farrow, Laurel K Willig, Darrell L Dinwiddie, Josh E Petrikin, Sarah E Soden, Suzanne Herd, Margaret Gibson,[...]. NPJ Genom Med 2016
65
33

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
Andrea Gaedigk, Magnus Ingelman-Sundberg, Neil A Miller, J Steven Leeder, Michelle Whirl-Carrillo, Teri E Klein. Clin Pharmacol Ther 2018
209
33

Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative Project.
Andrea Gaedigk, Amy Turner, Robin E Everts, Stuart A Scott, Praful Aggarwal, Ulrich Broeckel, Gwendolyn A McMillin, Roberta Melis, Erin C Boone, Victoria M Pratt,[...]. J Mol Diagn 2019
32
33

Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data.
Xiao Chen, Fei Shen, Nina Gonzaludo, Alka Malhotra, Cande Rogert, Ryan J Taft, David R Bentley, Michael A Eberle. Pharmacogenomics J 2021
22
33


Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.
Yao Yang, Mariana R Botton, Erick R Scott, Stuart A Scott. Pharmacogenomics 2017
57
33

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
J A Johnson, K E Caudle, L Gong, M Whirl-Carrillo, C M Stein, S A Scott, M T Lee, B F Gage, S E Kimmel, M A Perera,[...]. Clin Pharmacol Ther 2017
298
22

Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey.
Audrey Sabbagh, Pierre Darlu, Brigitte Crouau-Roy, Estella S Poloni. PLoS One 2011
95
22

Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.
Katy Walker, Gary Ginsberg, Dale Hattis, Douglas O Johns, Kathryn Z Guyton, Babasaheb Sonawane. J Toxicol Environ Health B Crit Rev 2009
88
22

NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.
Supharat Suvichapanich, Koya Fukunaga, Hilyatuz Zahroh, Taisei Mushiroda, Surakameth Mahasirimongkol, Licht Toyo-Oka, Usa Chaikledkaew, Jiraphun Jittikoon, Rika Yuliwulandari, Hideki Yanai,[...]. Pharmacogenet Genomics 2018
18
22

Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives.
Supatat Chumnumwat, Zen Huat Lu, Chonlaphat Sukasem, Michael David Winther, Francis R Capule, Asma A Apos Tiyah Abdul Hamid, Bibek Bhandari, Usa Chaikledkaew, Noppadol Chanhom, Soranun Chantarangsu,[...]. Public Health Genomics 2019
15
22

Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset.
Adam S Gordon, Holly K Tabor, Andrew D Johnson, Beverly M Snively, Themistocles L Assimes, Paul L Auer, John P A Ioannidis, Ulrike Peters, Jennifer G Robinson, Lara E Sucheston,[...]. Hum Mol Genet 2014
64
22

Targeted next generation sequencing as a tool for precision medicine.
Markus Gulilat, Tyler Lamb, Wendy A Teft, Jian Wang, Jacqueline S Dron, John F Robinson, Rommel G Tirona, Robert A Hegele, Richard B Kim, Ute I Schwarz. BMC Med Genomics 2019
30
22

Moving towards individualized medicine with pharmacogenomics.
William E Evans, Mary V Relling. Nature 2004
482
22

Global patterns of genetic diversity and signals of natural selection for human ADME genes.
Jing Li, Luyong Zhang, Hang Zhou, Mark Stoneking, Kun Tang. Hum Mol Genet 2011
57
22

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
C H van der Wouden, A Cambon-Thomsen, E Cecchin, K C Cheung, C L Dávila-Fajardo, V H Deneer, V Dolžan, M Ingelman-Sundberg, S Jönsson, M O Karlsson,[...]. Clin Pharmacol Ther 2017
164
22

Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study.
Frederick E Dewey, Michael F Murray, John D Overton, Lukas Habegger, Joseph B Leader, Samantha N Fetterolf, Colm O'Dushlaine, Cristopher V Van Hout, Jeffrey Staples, Claudia Gonzaga-Jauregui,[...]. Science 2016
331
22

HLA-B*5701 screening for hypersensitivity to abacavir.
Simon Mallal, Elizabeth Phillips, Giampiero Carosi, Jean-Michel Molina, Cassy Workman, Janez Tomazic, Eva Jägel-Guedes, Sorin Rugina, Oleg Kozyrev, Juan Flores Cid,[...]. N Engl J Med 2008
22

Real-time DNA sequencing from single polymerase molecules.
John Eid, Adrian Fehr, Jeremy Gray, Khai Luong, John Lyle, Geoff Otto, Paul Peluso, David Rank, Primo Baybayan, Brad Bettman,[...]. Science 2009
22

Requirements for comprehensive pharmacogenetic genotyping platforms.
Volker M Lauschke, Magnus Ingelman-Sundberg. Pharmacogenomics 2016
32
22


Deep mutational scanning: a new style of protein science.
Douglas M Fowler, Stanley Fields. Nat Methods 2014
470
22



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.